Abstract. A 45-year-old Japanese woman, treated for Bartter's syndrome for 14 years, presented with complaints of numbness in her extremities and polyarthralgia.
BARTTER'S syndrome, first reported in 1962, is characterized by hypokalemia, metabolic alkalosis, hyperreninemia, hyperplasia of the juxtaglomerular cells and normal blood pressure [1] . Gitelman's syndrome was initially reported as a "familial disorder characterized by hypokalemia and hypomagnesemia" in 1966 [2] . These disorders had been often confused because of their similar clinical features, but urinary calcium levels have been clinically useful in separating patients with primary hypokalemic metabolic alkalosis into two groups, i.e. classic Bartter's syndrome and Gitelman's syndrome [3] . Recently the pathogenesis of Gitelman's syndrome has been reported to be mutations of the gene encoding thiazide-sensitive Na-Cl cotransporter [4] .
In addition, hypomagnesemia has been associated on several occasions with calcium pyrophosphate deposition disease (CPPDD, chondrocalcinosis).
Since the first report in 1978 of the association between Bartter's syndrome and chondrocalcinosis, 25 cases have been published [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Because all the data in these reports showed hypomagnesemia and hypocalciuria, they might indicate Gitelman's syndrome, not Bartter's syndrome.
In this paper, we describe a patient with Gitelman's syndrome and chondrocalcinosis who has been successfully treated with spironolactone and magnesium supplementation.
Case Report
A 45-year-old Japanese woman was admitted to our hospital in December, 1994 for evaluation of numbness in her extremities and dyspnea. There was no family member with similar symptoms or renal disease, and her parents were nonconsanguineous.
She grew up normally and had no childhood history of tetany. There also was no history of vomiting or gastrointestinal disease, or abuse of diuretics, laxatives or other medications.
Hypokalemia had been first revealed in 1980 when she initially experienced dyspnea and numbness in her extremities. Because of hyperreninemia, hyperaldosteronism, the resistance to the pressor effects of angiotensin II, and hyperplasia of her juxtaglomerular cells, she had been diagnosed as having Bartter's syndrome in the former hospital. Since she came to our hospital with complaints of palpitation, numbness and dyspnea in 1982, she has been treated with spironolactone (25 mg/day) and potassium supplementation (32 mEq/day). Although her serum potassium concentration was slightly increased and maintained at 2.9-3.3 mEq/l with medication, mild numbness and dyspnea continued with gradual progression. The dose of spironolactone could not be increased to more than 50 mg/day, because prolongation of menstruation was found to be due to the drug. Meanwhile, hypomagnesemia was discovered in 1986.
Since 1990 she had been suffering from recurrent episodes of pain in her knees, shoulders and elbows; these attacks, lasting several days, were accompanied by a fever and improved by the administration of non steroidal anti inflammatory drugs. In 1992 chondrocalcinosis was found to be due to calcification in the joint spaces in her knees and symphysis pubis.
On physical examination, her height was 150.3 cm and weight 39.2 kg. Her blood pressure was 92/60 mmHg. Trousseau's sign and Chvostek's sign were both absent.
Laboratory data on admission revealed total serum protein, 6.8 mg/dl; serum albumin, 4.5 mg/ dl; creatinine, 0.5 mg/dl; blood urea nitrogen, 10 mg/dl; and uric acid, 4.1 mg/dl. Serum values included the following: sodium, 137 mEq/l; potassium, 2.8 mEq/l; chloride, 102 mEq/l; magnesium, 1.2 mEq/l (normal 1.6-2.1 mEq/l); calcium, 5.0 mEq/l; ionized calcium, 2.64 mEq/l (normal 2.27-2.63 mEq/l); and phosphate, 1.4 mEq/ 1. Urinary potassium was 55.8 mEq/day; urinary chloride, 138.6 mEq/day; urinary magnesium, 7.7 mEq/day; and urinary calcium, 0.54 mEq/day. The endogenous creatinine clearance was 119.9 m1/min. The molar urinary calcium/creatinine ratio was 0.04. On hormonal examination, the plasma renin activity was 37.3 ng/m1/h; aldosterone, 45 ng/dl; angiotensin I, 2760 pg/mi (normal <500 pg/dl); angiotensin II, 160 pg/mi (normal 9-47 pg/m1); and intact PTH, 27 pg/ml.
The intravenous infusion of 72 mEq magnesium (3.6 g magnesium sulfate) caused the serum magnesium level to transiently increase to 2.2 mEq/1 before decreasing to 1.5 mEq/l the next day. The urinary excretion of magnesium was 33 mEq/day, suggesting that the renal magnesium wasting was responsible for the hypomagnesemia.
Radiographs revealed chondrocalcinosis of the menisci in the knees ( Fig.  1 ) and symphysis pubis (Fig. 2) .
Treatment with increasing doses of spironolactone (50 mg/day) and oral magnesium (magnesium oxide 0.3 g/day) was started, along with continuation of the potassium supplementation.
Although the serum potassium level increased to greater than 3 mEq/l, the serum magnesium level did not change. Weekly intravenous drip infusion of magnesium sulfate (32 mEq) was therefore initiated.
Despite persistent hypomagnesemia, the polyarthralgia improved and the high fever had been reduced (Fig. 3 ). The clinical course of our patient, a 45-year-old Ja chondrocalcinosis. but the physiological features of Gitelman's syndrome appear to be derived from a mutation in TSC, because these same effects are seen in patients taking thiazide diuretics, specific inhibitors of TSC [4] .
There are reports indicating that concentrations of ionized calcium are normal [25] or low [26] with a normal level of PTH and an association between hypocalciuria and a reduction in fractional excretion of ionized calcium in patients with Gitelman's syndrome.
Colussi et al. suggested the possibility of an abnormal ionized calcium-PTH relationship related to hypomagnesemia [25] . Our patient had polyarthralgia due to chondrocalcinosis for ten years after revealing hypokalemia.
Twenty-five cases of Bartter's syndrome with chondrocalcinosis including familial presentation have been reported since 1978 [5] , and hypomagnesemia was always presented in these cases ( Table  1 ). The mean age at revealing hypokalemia in these cases was 42.8 years old, which is a late presentation for Bartter's syndrome. The fact that all the patients (except one), with urinary calcium had hypocalciuria, also indicated that these cases had a high possibility of Gitelman 
